Corline Biomedical AB's total assets for Q4 2025 were kr98.58M, an increase of 19.76% from the previous quarter. SE:CLBIO total liabilities were kr4.82M for the fiscal quarter, a -5.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.